ARDENT HEALTH PARTNERS INC (ARDT) Stock Analyst Ratings
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 81% to ARDT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.24. This target is 59.97% above the current price.
ARDT was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ARDT.
In the previous month the buy percentage consensus was at a similar level.
ARDT was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-06 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-11-06 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-10-11 | Keybanc | Initiate | Overweight |
| 2024-09-19 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-08-16 | Loop Capital | Maintains | Buy -> Buy |
| 2024-08-16 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-08-15 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-08-12 | Leerink Partners | Initiate | Outperform |
| 2024-08-12 | Mizuho | Initiate | Outperform |
| 2024-08-12 | RBC Capital | Initiate | Outperform |
| 2024-08-12 | Loop Capital | Initiate | Buy |
| 2024-08-12 | Truist Securities | Initiate | Buy |
| 2024-08-12 | JP Morgan | Initiate | Neutral |
| 2024-08-12 | B of A Securities | Initiate | Buy |
| 2024-08-12 | Morgan Stanley | Initiate | Overweight |
| 2024-08-12 | Citigroup | Initiate | Buy |